1,059
Participants
Start Date
November 30, 1996
Study Completion Date
September 30, 2004
Anastrozole
oral
Tamoxifen
oral
Research Site, Albstadt
Research Site, Berlin
Research Site, Cloppenburg
Research Site, Eggenfelden
Research Site, Frankfurt
Research Site, Freiburg im Breisgau
Research Site, Göttingen
Research Site, Halle
Research Site, Hamburg
Research Site, Hanau
Research Site, Hanover
Research Site, Heidelberg
Research Site, Hoyerswerda
Research Site, Idar-Oberstein
Research Site, Jena
Research Site, Karlsruhe
Research Site, Kassel
Research Site, Kiel
Research Site, Leonberg
Research Site, Lingen
Research Site, Lübeck
Research Site, Magdeburg
Research Site, Mainz
Research Site, Mannheim
Research Site, München
Research Site, Münster
Research Site, Neustadt
Research Site, Osnabrück
Research Site, Paderborn
Research Site, Pforzheim
Research Site, Recklinghausen
Research Site, Rosenheim
Research Site, Rostock
Research Site, Rüsselsheim am Main
Research Site, Schleswig
Research Site, Siegen
Research Site, Titisee-Neustadt
Research Site, Tübingen
Research Site, Ulm
Research Site, Waiblingen
Research Site, Westerstede
Research Site, Worms
Research Site, Würzburg
Lead Sponsor
German Adjuvant Breast Cancer Group
OTHER
AstraZeneca
INDUSTRY